A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...

Under the new leadership of Marty Makary, the FDA should focus more attention on the critical role of real-world clinical data — such as from health insurance databases — in the ongoing assessment of ...

Clinical trials refer to medical research that involves testing new treatments on people. The four phases help to ensure the trial's safety and effectiveness.

Dublin, May 19, 2025 (GLOBE NEWSWIRE) -- The "Thrombocytopenia - Global Clinical Trials Review, 2025" has been added to ResearchAndMarkets.com's offering. This extensive report offers key top-line ...

This extensive report offers key top-line data concerning ongoing Thrombocytopenia trials and explores trial numbers and their average enrollments across leading countries globally. It strategically ...

Nordic Capital and Riverside see investment opportunities in interoperability, automation and compliance software for global clinical trials.

As Australians face roadblocks to find clinical trials, doctors are calling for a reform of the system to improve access to potentially life-saving studies.

Clinical trials help doctors and researchers assess the effectiveness and safety of medical treatments. Individuals at higher risk for a condition who meet specific criteria may qualify to join a ...

About Emerald Clinical Trials Emerald Clinical Trials is a leading clinical research organization operating worldwide that serves over 100 biotechs, and 6 of the top 10 pharmaceutical companies.

As Trump targets DEI practices, 4 pharmas reaffirm commitment to diversifying clinical trials By Darren Incorvaia Feb 27, 2025 8:00am Diversity in clinical trials Eli Lilly Sanofi Bristol Myers Squibb ...

There are currently dozens of clinical trials examining new ways to treat mantle cell lymphoma (MCL). People can learn about trial recruitment at ClinicalTrials.gov.

The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their bodies, with no access to monitoring or care.